Question 67

A pharmacy dispensing hydralazine instead of the intended hydroxyzine

Reporting a situation where a pharmacy dispenses the wrong medication, such as hydralazine instead of hydroxyzine, is crucial for patient safety and is considered a medication error that should be reported to ISMP MERP.

A) A patient experiencing an unexpected side effect after taking a new medication

While unexpected side effects are concerning, they do not typically fall under the definition of a medication error. This situation is more related to pharmacovigilance and should be reported to regulatory agencies rather than ISMP MERP.

B) A patient experiencing therapeutic failure after switching generic manufacturers

Therapeutic failure due to switching generic manufacturers may indicate issues with drug efficacy, but it does not represent a direct medication error in dispensing. Therefore, this scenario is not appropriate for reporting to ISMP MERP.

C) A pharmacy dispensing hydralazine instead of the intended hydroxyzine

This situation exemplifies a clear medication error where the wrong drug is dispensed, posing significant risk to the patient. Reporting this error to ISMP MERP is essential to prevent future occurrences and enhance patient safety.

D) A pharmacy technician suspecting that a medication might be counterfeit

Although counterfeit medications are a serious concern, suspicion alone does not constitute a medication error that has occurred during the dispensing process. This situation should be investigated, but it is not the same as reporting a confirmed error to ISMP MERP.

Conclusion

The correct answer, C, highlights a specific medication error involving the dispensing of the incorrect medication, which is exactly the type of incident that ISMP MERP aims to collect data on for improving safety practices. In contrast, the other options either relate to adverse effects, therapeutic failures, or suspicions rather than confirmed errors, making them inappropriate for reporting in this context.